A NOVEL EXTENDED RELEASE FORMULATION OF TORSEMIDE ENHANCES NATRIURESIS WITHOUT LOWERING GFR IN NORMAL HUMAN SUBJECTS

  • Shen W
  • Khwaja F
  • Feig P
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Background: Loop diuretics have outstanding acute natriuretic and diuretic actions. However, their therapeutic efficacy is limited by a modest depletion of body salt or water due to the compensatory increase in renal sodium reabsorption after diuretic effects wear off. We tested the hypothesis that a more prolonged duration of action would enhance salt and water loss. Methods: Ten normal subjects received 20 mg of oral torsemide on two occasions while consuming a fixed diet with 300 mmol.day-1 of Na+. They were randomized to an immediate release (IR) or to an Extended Release (ER) formulation. The ER formulation delivered torsemide into solution over 12 hours. Results: Compared to IR, the plasma levels of torsemide in the subjects given ER were 59% lower 1-3 hours after dosing, accompanied by a lower naturieses, but were 97% higher 8-10 hours after dosing, leading to a 2-fold increased naturiesis. This resulted in a 2.4-fold prolongation of time to maximal levels and a >2-fold increase in excreted fluid (1634 + 385 versus 728 + 445 mL; P < 0.02) and Na+ (98 + 15 versus 42 + 17 mmol; P < 0.05) despite an 18% reduction in torsemide bioavailability. Only after ER was there a reduction on mean blood pressure (-2.9 + 1.8 vs +1.3+ 1.2 mmHg; P<0.05) and weight (-0.5 + 0.2 kg; P < 0.05) but only after IR was there a significant reduction in creatinine clearance (CCR; -24.5 + 6.6 ml*min-1 per 1.73 m-2; P < 0.005). The higher Na+ excretion and relatively well preserved CCR after ER resulted in a similar increase in fractional excretion of Na+ after ER and IR. Neither drug led to a significant loss of potassium. Conclusion: An ER formulation of torsemide led to a doubling of the time to peak plasma levels and loss of salt and water without reducing GFR resulting in significant reductions in weight and mean BP despite a high salt intake.

Cite

CITATION STYLE

APA

Shen, W., Khwaja, F., Feig, P. U., Shah, S., & Wilcox, C. (2014). A NOVEL EXTENDED RELEASE FORMULATION OF TORSEMIDE ENHANCES NATRIURESIS WITHOUT LOWERING GFR IN NORMAL HUMAN SUBJECTS. Journal of the American College of Cardiology, 63(12), A1401. https://doi.org/10.1016/s0735-1097(14)61401-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free